Centerstone Investors’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-91,243
Closed -$2.62M 23
2020
Q4
$2.62M Sell
91,243
-17,000
-16% -$459K 2.53% 16
2020
Q3
$2.64M Sell
108,243
-145,000
-57% -$3.13M 2.7% 16
2020
Q2
$4.53M Sell
253,243
-117,000
-32% -$1.54M 4.38% 9
2020
Q1
$3.01M Buy
370,243
+59,026
+19% +$674K 2.73% 17
2019
Q4
$4.11M Buy
311,217
+140,400
+82% +$1.7M 2.94% 13
2019
Q3
$2.03M Buy
170,817
+57,000
+50% +$1.06M 1.39% 25
2019
Q2
$2.78M Buy
113,817
+75,700
+199% +$2.18M 1.74% 27
2019
Q1
$1.21M Buy
+38,117
New +$1.35M 0.87% 29

Other funds holding CVET

Centerstone Investors's CVET Position: Q1 2021 in Review

Centerstone Investors sold out of Covetrus, Inc. Common Stock (CVET) in Q1 2021, closing a stake of 91,243 shares — an estimated $2.62M sold.

Centerstone Investors first reported a position in CVET in Q1 2019 and held it in 8 quarters. The position peaked at $4.53M in Q2 2020. 273 funds tracked by Wall St. Rank hold CVET as of Q1 2021.

  • Centerstone Investors reported no remaining Covetrus, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Centerstone Investors sold 91,243 Covetrus, Inc. Common Stock shares in Q1 2021, an estimated $2.62M.
  • Centerstone Investors first reported a position in Covetrus, Inc. Common Stock in Q1 2019 and held it in 8 quarters.
  • Centerstone Investors's Covetrus, Inc. Common Stock position peaked at $4.53M in Q2 2020.
  • 273 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q1 2021.

Based on Centerstone Investors's 13F filing for Q1 2021, filed 17 May 2021.